These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 6701496)
1. [Comparison of antibacterial activities of cephalosporins]. Kayser FH; Kohler ML Schweiz Med Wochenschr; 1984 Feb; 114(5):156-61. PubMed ID: 6701496 [TBL] [Abstract][Full Text] [Related]
2. [Activity of new beta-lactam antibiotics]. Cullmann W; Stieglitz M Fortschr Med; 1982 May; 100(19):888-92. PubMed ID: 6807788 [TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972 [TBL] [Abstract][Full Text] [Related]
4. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)]. Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287 [TBL] [Abstract][Full Text] [Related]
5. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains]. Mascellino MT; Prignano G; Iegri F; Lorenzi A Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234 [TBL] [Abstract][Full Text] [Related]
6. [In vitro effect of ceftriaxone on hospital bacteria. Line of regression and critical values]. Cluzel M; Chanal M; Sirot D; Sirot J; Cluzel R Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):473-6. PubMed ID: 3937122 [TBL] [Abstract][Full Text] [Related]
7. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385 [TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study]. Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442 [TBL] [Abstract][Full Text] [Related]
9. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)]. Deforges L; Le Van Thoi J; Soussy CJ; Duval J Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282 [TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria]. Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of a new semisynthetic cephalosporin: cefoperazone. Auckenthaler R; Waldvogel FA Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401 [TBL] [Abstract][Full Text] [Related]
12. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values]. Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773 [TBL] [Abstract][Full Text] [Related]
13. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species]. Schröter G; Schrettenbrunner A; Strenzel I Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
15. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins]. Croize J; Le Noc P; Bryskier A; Robert J Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128 [TBL] [Abstract][Full Text] [Related]
16. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates. Corser CA; Day GJ; Humble MW N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246 [TBL] [Abstract][Full Text] [Related]
17. [Multicenter study of the antibacterial activity of a new cephalosporin: CM 40874]. Duval J; Soussy CJ; Deforges L; Brun Y; Coulet M; Forey F; Thabaut A; Meyran M; Acar JF; Kitzis MD Pathol Biol (Paris); 1984 May; 32(5):331-4. PubMed ID: 6547524 [TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine]. Berche P; Gaillard JL Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779 [TBL] [Abstract][Full Text] [Related]
19. [Comparative bacteriostatic activity of 10 cephalosporins against 100 strains of Serratia]. Quentin C; de Barbeyrac B; Savary N; Texier J; Bebear C Pathol Biol (Paris); 1983 May; 31(5):379-82. PubMed ID: 6353328 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon]. Baumgärtner M; Grehn M; Wundt W Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]